コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 g intramuscular pasireotide in patients with Cushing's disease.
2 y challenging in patients with acromegaly or Cushing's disease.
3 ion, schizophrenia, Alzheimer's disease, and Cushing's disease.
4 hat are frequently observed in patients with Cushing's disease.
5 ng-term survival prospects for patients with Cushing's disease.
6 study, we randomly assigned 162 adults with Cushing's disease and a urinary free cortisol level of a
7 T studies that were done on 13 patients with Cushing's disease and compared the results with those ob
10 mpared mortality rates between patients with Cushing's disease and the general population, and expres
12 concentration in about 40% of patients with Cushing's disease at month 7 and had a similar safety pr
13 ublications, were diagnosis and treatment of Cushing's disease, being cured of hypercortisolism for a
14 operty of LCI699 prompted its development in Cushing's disease, but limited more extensive clinical s
18 entiating a pituitary source of excess ACTH (Cushing's disease) from an ectopic source is accomplishe
21 opic bilateral adrenalectomy for symptomatic Cushing's disease is a safe and effective treatment opti
23 d cerebral glucose metabolism we observed in Cushing's disease is attributable to increased glucocort
27 experience considerable improvement in their Cushing's disease symptoms, and their quality of life eq
28 ients undergoing bilateral adrenalectomy for Cushing's disease through either the anterior or posteri
29 urrent, or de-novo (non-surgical candidates) Cushing's disease who had a mean urinary free cortisol (
31 ious treatment option for some patients with Cushing's disease who have persistent or recurrent disea
32 decrease in cortisol levels in patients with Cushing's disease who received pasireotide supports its
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。